This inventor holds 2 USPTO granted patents. Top assignee: Aventis Pharma S.a.. Active years: 2005-2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2005-2007
Title: Emmanuelle Renou: Innovator in Cancer Therapy
Introduction
Emmanuelle Renou is a prominent inventor based in Paris, France. She has made significant contributions to the field of cancer therapy through her innovative research and development of novel chemical compounds.
Latest Patents
Emmanuelle Renou holds 2 patents related to her work on chemical derivatives and their application as antitelomerase agents. Her inventions focus on cancer therapy and introduce novel anticancer agents that inhibit telomerase, a key enzyme involved in cancer cell proliferation. These chemical compounds have promising therapeutic applications in humans, potentially offering new avenues for cancer treatment.
Career Highlights
Emmanuelle is currently associated with Aventis Pharma S.A., where she continues to advance her research in oncology. Her work has garnered attention for its potential impact on cancer therapies, making her a valuable asset in the pharmaceutical industry.
Collaborations
Throughout her career, Emmanuelle has collaborated with notable colleagues, including Patrick Mailliet and Marcel Alasia. These partnerships have enriched her research and contributed to the development of her innovative patents.
Conclusion
Emmanuelle Renou's contributions to cancer therapy through her patents and collaborations highlight her role as a leading inventor in the field. Her work continues to inspire advancements in medical research and treatment options for cancer patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile